6-shogaol is a potential treatment for Head and Neck Squamous Cell Carcinoma
Cheng‐Ming Hsu(Chang Gung University), Shun‐Fu Chang(Chiayi Chang Gung Memorial Hospital)
Cited by 12
Related Papers
NVP-BEZ235, a dual PI3K-mTOR inhibitor, suppresses the growth of FaDu hypopharyngeal squamous cell carcinoma and has a synergistic effect with Cisplatin
|Cell Death Discovery|2018|48
NVP-BEZ235 Attenuated Cell Proliferation and Migration in the Squamous Cell Carcinoma of Oral Cavities and p70S6K Inhibition Mimics its Effect
|International Journal of Molecular Sciences|2018|14
Dihydroisotanshinone I and BMAL-SIRT1 Pathway in an In Vitro 6-OHDA-Induced Model of Parkinson’s Disease
|International Journal of Molecular Sciences|2023|9
Effects of Visfatin on Intracellular Mechanics and Catabolism in Human Primary Chondrocytes through Glycogen Synthase Kinase 3β Inactivation
|International Journal of Molecular Sciences|2021|7